Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Interventions

sodium thiosulfate 2 ebselen 2 Ankle Brachial Index 2 Acetylcysteine 2 Tomography, X-Ray Computed 1 Sodium Chloride 1 Saline Solution 1 Ringer's Lactate 1 Platinum 1 Ofloxacin 1 Magnetic Resonance Spectroscopy 1 Magnetic Resonance Imaging 1 Hyaluronic Acid 1 Hearing Tests 1 Hearing 1 Ear Protective Devices 1 Cisplatin 1 Audiometry, Pure-Tone 1 Atorvastatin 1 Acoustic Impedance Tests 1 1,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Hearing Loss × Ear Protective Devices × Clear all

NCT04609982 2024-08-21

SSNHL in Head & Neck Cancer Patients

Nova Scotia Health Authority

Phase NA Withdrawn

Hearing Loss

Data powered by HemOnc (CC BY 4.0) Colophon ⚡